Piotr Kedzierawski

Dr. Piotr Kedzierawski

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2021 in Sensors
Verified
Journal Article
Open access
PDF file
MWMarek Wodzinski
Marek Wodzinski
ICIzabela Ciepiela
Izabela Ciepiela
TKTomasz Kuszewski
Tomasz Kuszewski
PKPiotr Kedzierawski
Piotr Kedzierawski
ASAndrzej Skalski
Andrzej Skalski
Breast-conserving surgery requires supportive radiotherapy to prevent cancer recurrence. However, the task of localizing the tumor bed to be irradiated is not trivial. The automatic image registration could significantly aid the tumor bed localization and lower the radiation dose delivered to the surrounding healthy tissues. This study proposes a novel image registration method dedicated to breast tumor bed localization addressing the problem of missing data due to tumor resection that may be applied to real-time radiotherapy planning. We propose a deep learning-based nonrigid image registration method based on a modified U-Net architecture. The algorithm works simultaneously on several image resolutions to handle large deformations. Moreover, we propose a dedicated volume penalty that introduces the medical knowledge about tumor resection into the registration process. The proposed method may be useful for improving real-time radiation therapy planning after the tumor resection and, thus, lower the surrounding healthy tissues’ irradiation. The data used in this study consist of 30 computed tomography scans acquired in patients with diagnosed breast cancer, before and after tumor surgery. The method is evaluated using the target registration error between manually annotated landmarks, the ratio of tumor volume, and the subjective visual assessment. We compare the proposed method to several other approaches and show that both the multilevel approach and the volume regularization improve the registration results. The mean target registration error is below 6.5 mm, and the relative volume ratio is close to zero. The registration time below 1 s enables the real-time processing. These results show improvements compared to the classical, iterative methods or other learning-based approaches that do not introduce the knowledge about tumor resection into the registration process. In future research, we plan to propose a method dedicated to automatic localization of missing regions that may be used to automatically segment tumors in the source image and scars in the target image.

9 October 2021 in Cells
Verified
Journal Article
Open access
PDF file
AWAneta Węgierek-Ciuk
Aneta Węgierek-Ciuk
ALAnna Lankoff
Anna Lankoff
HLHalina Lisowska
Halina Lisowska
PKPiotr Kedzierawski
Piotr Kedzierawski
PAPamela Chiaka Akuwudike
Pamela Chiaka Akuwudike
AWAndrzej Wojcik
Andrzej Wojcik
Gynaecologic cancers are common among women and treatment includes surgery, radiotherapy or chemotherapy, where the last two methods induce DNA damage in non-targeted cells like peripheral blood lymphocytes (PBL). Damaged normal cells can transform leading to second malignant neoplasms (SMN) but the level of risk and impact of risk modifiers is not well defined. We investigated how radiotherapy alone or in combination with chemotherapy induce DNA damage in PBL of cervix and endometrial cancer patients during therapy. Blood samples were collected from nine endometrial cancer patients (treatment with radiotherapy + chemotherapy—RC) and nine cervical cancer patients (treatment with radiotherapy alone—R) before radiotherapy, 3 weeks after onset of radiotherapy and at the end of radiotherapy. Half of each blood sample was irradiated ex vivo with 2 Gy of gamma radiation in order to check how therapy influenced the sensitivity of PBL to radiation. Analysed endpoints were micronucleus (MN) frequencies, apoptosis frequencies and cell proliferation index. The results were characterised by strong individual variation, especially the MN frequencies and proliferation index. On average, despite higher total dose and larger fields, therapy alone induced the same level of MN in PBL of RC patients as compared to R. This result was accompanied by a higher level of apoptosis and stronger inhibition of cell proliferation in RC patients. The ex vivo dose induced fewer MN, more apoptosis and more strongly inhibited proliferation of PBL of RC as compared to R patients. These results are interpreted as evidence for a sensitizing effect of chemotherapy on radiation cytotoxicity. The possible implications for the risk of second malignant neoplasms are discussed.

1 May 2017 in Reports of Practical Oncology and Radiotherapy
Verified
Journal Article
Closed access
PKPiotr Kedzierawski
Piotr Kedzierawski
RSRafał Stando
Rafał Stando
PMPaweł Macek
Paweł Macek
The aim of the study was the evaluation of the effectiveness of radiotherapy in patients with the feet pain caused by heel spurs. Treatment options for patients reporting these symptoms include use of suitable orthopedic footwear, the use of general or topical non-steroidal anti-inflammatory drugs or steroids, physiotherapy, manual therapy, shock wave or appropriate surgical procedures. Radiotherapy is one of the method used in patients with chronic pain syndrome. The material consisted of 47 patients treated in Radiotherapy Department at the Holycross Cancer Center. The time of follow-up ranged from 1 to 129 months. After treatment patients were observed. During the first follow-up visit a complete relief of symptoms was observed in 37 patients, and the pain was felt by 10 patients for 4 months after the treatment. One patient was re-irradiated 6 months after treatment because of persistent pain. At 16 and 17 months after the onset of treatment, pain was reported by two patients. These patients were re-irradiated. One patient had recurrence of pain 48 months after completion of radiation. After the second irradiation the pain was relieved. The remaining patients, with the exception of two, experienced remission of pain, which has been documented. Tolerance of the treatment was very good. No complications of radiation were observed. Radiotherapy remains an attractive treatment for patients with inflammation of the heel fascia.

23 June 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
PKPiotr Kedzierawski
Piotr Kedzierawski
PMPaweł Macek
Paweł Macek
ICIzabela Ciepiela
Izabela Ciepiela
AKArtur Kowalik
Artur Kowalik
SGStanislaw Gozdz
Stanislaw Gozdz
The aim of this study was to evaluate the probability of pathologic complete regression (pCR) by the BRCA1 gene mutation status in patients with triple-negative breast cancer (TNBC) treated with neoadjuvant chemotherapy. The study involved 143 women (mean age 55.4 ± 13.1 years) with TNBC. The BRCA1 mutation was observed in 17% of the subjects. The most commonly used (85.3%) chemotherapy regimen was four cycles of adriamycine and cyclophosphamide followed by 12 cycles of paclitaxel (4AC + 12T). The differences between clinico-pathological factors by BRCA1 status were estimated. Odds ratios and 95% confidence intervals for pCR vs. non-pCR were calculated using logistic regression. The probability distribution of pCR based on BRCA1 status was estimated using beta distributions. The presence of T3–T4 tumours, cancer in stages II and III, lymphovascular invasion, and the use of chemotherapy schedules other than 4AC + 12T significantly decreased the odds of pCR. It was established that there was a 20% chance that pCR in patients with the BRCA1 mutation was 50% or more times as frequent than in patients without the mutation. Thus, the BRCA1 mutation can be a predictive factor for pCR in patients with TNBC.

30 July 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
MBMalgorzata Biskup
Malgorzata Biskup
PMPaweł Macek
Paweł Macek
SGStanislaw Gozdz
Stanislaw Gozdz
MTMalgorzata Terek-Derszniak
Malgorzata Terek-Derszniak
HKHalina Krol
Halina Krol
Marek ZakMarek Zak
Marek Zak
Objective: As overall spread of obesity in populations is generally acknowledged to result from unhealthy lifestyles rather than individual genetic makeup, this study aimed to gain specific insights into its determinants through assessing the prevalent associations between individual socioeconomic status (SES) and weight loss in overweight and obese men and women. Methods: A prospective, 2-year follow-up study covered 3362 (38.0% men) respondents, aged 43–64 years, body mass index ≥25 kg/m 2 . Changes in body weight were estimated as a percentage of initial weight. Three categories of changes were defined: gained ≥3%, stable (gained <3% or lost <3%), lost ≥3%. Body weight loss was determined against three categories: lost ≥3 to <5%, lost ≥5 to <10%, lost ≥10%. Select SES variables (ie, gender, age, education, marital status, occupational activity and income) were determined in line with the Health Status Questionnaire. The associations between SES and body weight changes were analysed with the aid of logistic regression models. The results were presented as ORs with 95% CIs. Results: Only 18% of the respondents had complied with the medical recommendations on weight loss. Significant differences were encountered between the gender, age and occupational activity variables and the weight loss one. Multifactorial models were used to determine the following gender-specific associations between SES and weight loss. Men with moderate income had significantly higher odds for weight loss (≈75%), as compared with the higher earners, whereas women with low income, occupationally inactive, had significantly higher odds (≈30% and ≈50%, respectively), as compared with the high earners and occupationally active ones. Conclusions: Lower education, male gender, lower income per household, older age and unemployment status were the established factors predisposing to obesity. While aiming to ensure effectiveness of the measures specifically aimed at preventing obesity, population groups deemed most at risk of potential weight gain must prior be identified.

5 October 2020 in Nowotwory. Journal of Oncology
Verified
Journal Article
Open access
PDF file
PKPiotr Kedzierawski
Piotr Kedzierawski
Invasive breast cancer is the most common malignancy in women. At present, in the majority of cases it is recognized at an early stage. Its most common site of metastasis is the axilla region, and for women without clinically suspected lymph nodes a sentinel lymph node biopsy (SLNB) is the method of choice in diagnostics and treatment process. It allows, in many cases, axillary lymphadenectomy to be avoided and the risk of complications after a surgical treatment to be dimi­nished. Extracapsular extension (ECE) of nodal metastasis, defined as extension of cancer cells through the nodal capsule, is an important prognostic factor. The aim of this paper is to review the literature on ECE in the sentinel lymph node (SLN). Invasive breast cancer is the most common malignancy in women. At present, in the majority of cases it is recognized at an early stage. Its most common site of metastasis is the axilla region, and for women without clinically suspected lymph nodes a sentinel lymph node biopsy (SLNB) is the method of choice in diagnostics and treatment process. It allows, in many cases, axillary lymphadenectomy to be avoided and the risk of complications after a surgical treatment to be dimi­nished. Extracapsular extension (ECE) of nodal metastasis, defined as extension of cancer cells through the nodal capsule, is an important prognostic factor. The aim of this paper is to review the literature on ECE in the sentinel lymph node (SLN).